|
1
|
Murphy G, McCormack V, Abedi-Ardekani B,
Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC,
Fleischer DE, et al: International cancer seminars: A focus on
esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holubekova V, Mendelova A, Jasek K,
Mersakova S, Zubor P and Lasabova Z: Epigenetic regulation by DNA
methylation and miRNA molecules in cancer. Future Oncol.
13:2217–2222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng Y, Liang P, Geng H, Wang Z, Li L,
Cheng SH, Ying J, Su X, Ng KM, Ng MH, et al: A novel 19q13
nucleolar zinc finger protein suppresses tumor cell growth through
inhibiting ribosome biogenesis and inducing apoptosis but is
frequently silenced in multiple carcinomas. Mol Cancer Res.
10:925–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye L, Xiang T, Fan Y, Zhang D, Li L, Zhang
C, He X, Xiang Q, Tao Q and Ren G: The 19q13 KRAB Zinc-finger
protein ZFP82 suppresses the growth and invasion of esophageal
carcinoma cells through inhibiting NF-κB transcription and inducing
apoptosis. Epigenomics. 11:65–80. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fan Y, Zhan Q, Xu H, Li L, Li C, Xiao Q,
Xiang S, Hui T, Xiang T and Ren G: Epigenetic identification of
ZNF545 as a functional tumor suppressor in multiple myeloma via
activation of p53 signaling pathway. Biochem Biophys Res Commun.
474:660–666. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tao Q, Huang H, Geiman TM, Lim CY, Fu L,
Qiu GH and Robertson KD: Defective de novo methylation of viral and
cellular DNA sequences in ICF syndrome cells. Hum Mol Genet.
11:2091–2102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang
H, Kang W, Li X, Tao Q, Sung JJ and Yu J: Zinc-finger protein 545
is a novel tumour suppressor that acts by inhibiting ribosomal RNA
transcription in gastric cancer. Gut. 62:833–841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao Y, Xiang T, Luo X, Li C, Li Q, Peng
W, Li L, Li S, Wang Z, Tang L, et al: Zinc-finger protein 545
inhibits cell proliferation as a tumor suppressor through inducing
apoptosis and is disrupted by promoter methylation in breast
cancer. PLoS One. 9:e1109902014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng J, Liang H, Ying G, Dong Q, Zhang R,
Yu J, Fan D and Hao X: Poor survival is associated with the
methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter
in gastric cancer. Oncotarget. 6:4482–4495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Li X, Tao Q, Yu XL, Cheng ZG, Han
ZY, Guo M and Liang P: Hypermethylation of ZNF545 is associated
with poor prognosis in patients with early-stage hepatocellular
carcinoma after thermal ablation. Gut. 64:1836–1837. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaiser AM and Attardi LD: Deconstructing
networks of p53-mediated tumor suppression in vivo. Cell Death
Differ. 25:93–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shu KX, Li B and Wu LX: The p53 network:
P53 and its downstream genes. Colloids Surf B Biointerfaces.
55:10–18. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozaki T, Nakagawara A and Nagase H: RUNX
Family participates in the regulation of p53-dependent DNA damage
response. Int J Genomics. 2013:2713472013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Wu S, Su X and May WS: JAZ
mediates G1 cell-cycle arrest and apoptosis by positively
regulating p53 transcriptional activity. Blood. 108:4136–4145.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gottlieb TM, Leal JF, Seger R, Taya Y and
Oren M: Cross-talk between Akt, p53 and Mdm2: Possible implications
for the regulation of apoptosis. Oncogene. 21:1299–1303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Janicke RU, Sohn D and Schulze-Osthoff K:
The dark side of a tumor suppressor: Anti-apoptotic p53. Cell Death
Differ. 15:959–976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao D, Tahaney WM, Mazumdar A, Savage MI
and Brown PH: Molecularly targeted therapies for p53-mutant
cancers. Cell Mol Life Sci. 74:4171–4187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andries V, Vandepoele K, Staes K, Berx G,
Bogaert P, Van Isterdael G, Ginneberge D, Parthoens E,
Vandenbussche J, Gevaert K and van Roy F: NBPF1, a tumor suppressor
candidate in neuroblastoma, exerts growth inhibitory effects by
inducing a G1 cell cycle arrest. BMC Cancer. 15:3912015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mirzayans R, Andrais B, Kumar P and Murray
D: Significance of Wild-type p53 signaling in suppressing apoptosis
in response to chemical genotoxic agents: Impact on chemotherapy
outcome. Int J Mol Sci. 18(pii): E9282017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Selivanova G and Wiman KG: Reactivation of
mutant p53: Molecular mechanisms and therapeutic potential.
Oncogene. 26:2243–2254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Basile JR, Eichten A, Zacny V and Münger
K: NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis
factor alpha induces growth arrest and cytoprotection in normal
human keratinocytes. Mol Cancer Res. 1:262–270. 2003.PubMed/NCBI
|
